Scarica l'app Stockscreener
4.83
0.41%
-0.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXRX Giù?
Forum
Previsione
Precedente Chiudi:
$4.85
Aprire:
$4.96
Volume 24 ore:
16.97M
Relative Volume:
0.70
Capitalizzazione di mercato:
$2.06B
Reddito:
$64.60M
Utile/perdita netta:
$-377.75M
Rapporto P/E:
-3.1161
EPS:
-1.55
Flusso di cassa netto:
$-335.64M
1 W Prestazione:
+4.77%
1M Prestazione:
-10.72%
6M Prestazione:
-21.72%
1 anno Prestazione:
-25.69%
Intervallo 1D:
$4.80
$5.00
Intervallo di 1 settimana:
$4.51
$5.05
Portata 52W:
$3.79
$12.36
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
Nome
Recursion Pharmaceuticals Inc
Settore
Industria
Telefono
(385) 269-0203
Indirizzo
41S RIO GRANDE STREET, SALT LAKE CITY
Confronta RXRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
4.83 | 1.98B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-03 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-03-16 | Iniziato | Needham | Buy |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-03-04 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | Iniziato | Berenberg | Buy |
| 2021-05-11 | Iniziato | BofA Securities | Buy |
| 2021-05-11 | Iniziato | Goldman | Neutral |
| 2021-05-11 | Iniziato | JP Morgan | Neutral |
| 2021-05-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Recursion Pharmaceuticals Inc Borsa (RXRX) Ultime notizie
Recursion Pharmaceuticals, Inc. $RXRX Shares Purchased by Advisors Asset Management Inc. - MarketBeat
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading 8.7% HigherHere's What Happened - MarketBeat
Recursion Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:RXRX) - MarketBeat
Recursion Pharmaceuticals (NASDAQ:RXRX) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Is Recursion Pharmaceuticals (NASDAQ:RXRX) Using Debt In A Risky Way? - 富途牛牛
Recursion Pharmaceuticals Stock: An Exponential Climb? - timothysykes.com
Will Recursion Pharmaceuticals Rise or Fall? - StocksToTrade
RXRX’s Market Strategy: Analyzing Recent Developments - timothysykes.com
Oversold Conditions For Recursion Pharmaceuticals (RXRX) - Nasdaq
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia - MSN
Russell Investments Group Ltd. Has $206,000 Stock Position in Recursion Pharmaceuticals, Inc. $RXRX - MarketBeat
Is Recursion Pharmaceuticals Inc. forming a breakout patternJuly 2025 Big Picture & AI Forecast for Swing Trade Picks - beatles.ru
Ranking Recursion Pharmaceuticals Inc. among high performing stocks via toolsSwing Trade & Daily Price Action Insights - Newser
Recursion Pharmaceuticals Stock (RXRX) Opinions on AI-Driven Pipeline Updates - Quiver Quantitative
Tools to assess Recursion Pharmaceuticals Inc.’s risk profileJuly 2025 Opening Moves & Consistent Income Trade Ideas - Newser
Published on: 2025-09-08 04:20:29 - Newser
Applying Wyckoff theory to Recursion Pharmaceuticals Inc. stockQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - Newser
Using Ichimoku Cloud for Recursion Pharmaceuticals Inc. technicalsEarnings Trend Report & Precise Swing Trade Entry Alerts - Newser
Analyzing recovery setups for Recursion Pharmaceuticals Inc. investors2025 AllTime Highs & Real-Time Chart Breakout Alerts - Newser
Real time alert setup for Recursion Pharmaceuticals Inc. performanceBond Market & Free Community Consensus Stock Picks - Newser
Detecting support and resistance levels for Recursion Pharmaceuticals Inc.CEO Change & High Win Rate Trade Tips - Newser
Multi asset correlation models including Recursion Pharmaceuticals Inc.2025 Pullback Review & Expert Approved Momentum Ideas - Newser
How to read the order book for Recursion Pharmaceuticals Inc.Market Weekly Review & Verified Swing Trading Watchlist - Newser
Will Recursion Pharmaceuticals Inc. stock recover after recent drop2025 Technical Patterns & Reliable Price Action Trade Plans - Newser
Historical volatility pattern of Recursion Pharmaceuticals Inc. visualizedGold Moves & Weekly Chart Analysis and Guides - Newser
Volatility clustering patterns for Recursion Pharmaceuticals IncJuly 2025 Breakouts & High Yield Equity Trading Tips - Newser
Chart based exit strategy for Recursion Pharmaceuticals Inc.2025 Institutional Moves & Real-Time Volume Analysis - Newser
Recursion Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Big Picture & Weekly Market Pulse Updates - Newser
Can Recursion Pharmaceuticals Inc. rally from current levels2025 Price Momentum & AI Forecasted Entry and Exit Points - Newser
How to escape a deep drawdown in Recursion Pharmaceuticals Inc.Portfolio Return Report & Free Expert Approved Momentum Trade Ideas - Newser
S P Trends: Will Recursion Pharmaceuticals Inc. outperform tech stocksRecession Risk & Technical Entry and Exit Alerts - خودرو بانک
What’s the recovery path for long term holders of Recursion Pharmaceuticals Inc.Quarterly Profit Report & Risk Managed Investment Strategies - Newser
Will Recursion Pharmaceuticals Inc. see short term momentumIPO Watch & Real-Time Chart Pattern Alerts - Newser
Will Recursion Pharmaceuticals Inc. benefit from current market trends2025 Risk Factors & High Accuracy Swing Trade Signals - خودرو بانک
Is Recursion Pharmaceuticals Inc. in a long term uptrendInsider Buying & Safe Capital Growth Trade Ideas - خودرو بانک
Will Recursion Pharmaceuticals Inc. benefit from macro trendsMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Applying chart zones and confluence areas to Recursion Pharmaceuticals Inc.2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Forecasting Recursion Pharmaceuticals Inc. price range with options dataWeekly Profit Summary & Weekly High Conviction Trade Ideas - Newser
Is Recursion Pharmaceuticals Inc. a strong growth stockJuly 2025 Trade Ideas & Consistent Growth Equity Picks - خودرو بانک
Tools to monitor Recursion Pharmaceuticals Inc. recovery probability2025 Volatility Report & AI Driven Stock Movement Reports - Newser
Can technical indicators confirm Recursion Pharmaceuticals Inc.’s reversalAnalyst Upgrade & Real-Time Stock Entry Alerts - Newser
Can Recursion Pharmaceuticals Inc. hit a new high this monthTrade Analysis Summary & Verified Entry Point Detection - Newser
Visualizing Recursion Pharmaceuticals Inc. stock with heatmapsJuly 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
Recursion Pharmaceuticals' Strategic Position in TechBio and Clinical Pipeline Progress - AInvest
Pattern recognition hints at Recursion Pharmaceuticals Inc. upsideLayoff News & Safe Entry Point Alerts - Newser
Is Recursion Pharmaceuticals Inc. trending in predictive chart models2025 Investor Takeaways & High Accuracy Swing Entry Alerts - Newser
Aug Update: What is the Moat Score of Recursion Pharmaceuticals Inc.Risk Management & Low Volatility Stock Suggestions - خودرو بانک
Technical analysis overview for Recursion Pharmaceuticals Inc. stockJuly 2025 Momentum & Safe Investment Capital Preservation Plans - Newser
How liquid is Recursion Pharmaceuticals Inc. stock2025 Investor Takeaways & Free High Accuracy Swing Entry Alerts - خودرو بانک
Can machine learning forecast Recursion Pharmaceuticals Inc. recoveryJuly 2025 Summary & Fast Momentum Entry Tips - Newser
Recursion Pharmaceuticals shares rise 1.93% premarket as AI-driven drug discovery gains traction. - AInvest
Recursion Pharmaceuticals Inc Azioni (RXRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):